Qlucore Newsletter: IVDR Test for Pediatric Leukemia Now in Clinical Use

Rigshospitalet, Denmark's largest teaching and public hospital, uses Qlucore Diagnostics BCP-ALL. This milestone follows the launch of our CE-marked (IVDR) software to clinical laboratories across Europe at the end of February 2025. 

Rigshospitalet has been a long-term user of Qlucore Insights, and to ensure full compliance with regulatory requirements, they have now purchased Qlucore Diagnostics. The software enables both gene expression subtype classification of B-cell leukemias and gene fusion analysis support. It is the first CE-marked IVDR RNA-seq based test for BCP-ALL on the market today. 

Discover more about the genetic classification of leukemia and the role of RNA-sequencing as an emerging clinical diagnostic tool. Read our white paper HERE.